Study of LM-305 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) and Other Plasma Cell Diseases
Clinical trial NCT05647512 · WITHDRAWN
Trial details
- NCT number
- NCT05647512
- Sponsor
- LaNova Medicines Limited
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-18
- Primary completion
- 2024-12-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.